Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study
AUTOR(ES)
Tomlinson, Shannon K
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=113263Documentos Relacionados
- Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer
- Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
- 5-FLUOROURACIL AS A SELECTIVE AGENT FOR GROWTH OF LEPTOSPIRAE
- Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients
- Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines.